Search research articles
Contact Us
Filters
Showing results (271-280 of 548) with videos related to
Page
of 55
Sort By:
Neuropharmacology
|
May 1, 1988
The effect of long-term treatment with amine-depleting drugs or chlorpromazine on alpha-adrenoreceptors and 5-HT2 receptors in the brain of the rat
M Hong, E J Roots, P Jenner, et al.
Brain Research
|
January 4, 2006
3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor
M M Iravani, C O Haddon, S Rose, et al.
Advances in Neurology
|
September 14, 2001
Glial cells and abnormal protein handling in the pathogenesis of Parkinson's disease
K S McNaught, M Lee, D H Hyun, et al.
British Journal of Pharmacology
|
December 1, 1989
D1 or D2 receptor-induced purposeless chewing in rats is differentially modulated by cholinergic drugs
P Collins, C L Broekkamp, P Jenner, et al.
Biochemical Pharmacology
|
July 7, 1992
Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation
K L Thomas, S Rose, P Jenner, et al.
Neuroreport
|
May 8, 2001
6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum
B Ferger, S Rose, A Jenner, et al.
Neuroscience Letters
|
April 6, 1984
Functional increase in striatal dopaminergic activity following continuous long-term treatment with trifluoperazine
R Kerwin, N M Rupniak, P Jenner, et al.
Neuropharmacology
|
October 1, 1979
Clonazepam induces decreased serotoninergic activity in the mouse brain
J Pratt, P Jenner, E H Reynolds, et al.
Psychopharmacology
|
January 1, 1991
Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation
P Collins, C L Broekkamp, P Jenner, et al.
European Journal of Neurology
|
June 23, 2009
Levodopa in the treatment of Parkinson's disease
A H V Schapira, M Emre, P Jenner, et al.
Page
of 55
Search research articles
Search
Showing results (271-280 of 548) with videos related to
Sort By:
Page
of 55
Neuropharmacology
|
May 1, 1988
The effect of long-term treatment with amine-depleting drugs or chlorpromazine on alpha-adrenoreceptors and 5-HT2 receptors in the brain of the rat
M Hong, E J Roots, P Jenner, et al.
Brain Research
|
January 4, 2006
3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor
M M Iravani, C O Haddon, S Rose, et al.
Advances in Neurology
|
September 14, 2001
Glial cells and abnormal protein handling in the pathogenesis of Parkinson's disease
K S McNaught, M Lee, D H Hyun, et al.
British Journal of Pharmacology
|
December 1, 1989
D1 or D2 receptor-induced purposeless chewing in rats is differentially modulated by cholinergic drugs
P Collins, C L Broekkamp, P Jenner, et al.
Biochemical Pharmacology
|
July 7, 1992
Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation
K L Thomas, S Rose, P Jenner, et al.
Neuroreport
|
May 8, 2001
6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum
B Ferger, S Rose, A Jenner, et al.
Neuroscience Letters
|
April 6, 1984
Functional increase in striatal dopaminergic activity following continuous long-term treatment with trifluoperazine
R Kerwin, N M Rupniak, P Jenner, et al.
Neuropharmacology
|
October 1, 1979
Clonazepam induces decreased serotoninergic activity in the mouse brain
J Pratt, P Jenner, E H Reynolds, et al.
Psychopharmacology
|
January 1, 1991
Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation
P Collins, C L Broekkamp, P Jenner, et al.
European Journal of Neurology
|
June 23, 2009
Levodopa in the treatment of Parkinson's disease
A H V Schapira, M Emre, P Jenner, et al.
Page
of 55